Ligand profile
ZINC14998177
Virtual-screening candidate from ZINC.
Bound to: KP13_01350 — Pantothenate kinase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC14998177- UniProt (similar protein)
P9WPA7- Tanimoto
- 0.734
- Target protein
- KP13_01350
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 82.2
- −1 ≤ LogP ≤ 5 3.21
- MW ≤ 500 Da 390.4
- LogP ≤ 5 3.21
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 82.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@@H](NC(=O)c1ccco1)c1nnc(SCCOc2ccc(F)cc2)n1CC[C@@H](NC(=O)c1ccco1)c1nnc(SCCOc2ccc(F)cc2)n1C
InChI=1S/C18H19FN4O3S/c1-12(20-17(24)15-4-3-9-26-15)16-21-22-18(23(16)2)27-11-10-25-14-7-5-13(19)6-8-14/h3-9,12H,10-11H2,1-2H3,(H,20,24)/t12-/m1/s1InChI=1S/C18H19FN4O3S/c1-12(20-17(24)15-4-3-9-26-15)16-21-22-18(23(16)2)27-11-10-25-14-7-5-13(19)6-8-14/h3-9,12H,10-11H2,1-2H3,(H,20,24)/t12-/m1/s1
BSBVCWGGTIABHB-GFCCVEGCSA-NBSBVCWGGTIABHB-GFCCVEGCSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- ZVX
- Homolog
- P9WPA7
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC14998177 →
- ZINC ZINC20 ZINC14998177 →
- UniProt UniProt P9WPA7 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC14998177”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01350.
PDB 20
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).